Search results for

In 2006, Oregon successfully made pseudoephedrine, a key ingredient of meth, a prescription drug. Since then, Mother Jones' Jonah Engle reports, 24 states have tried to follow suit — and 23 have failed. Engle attributes those failures to pharmaceutical companies' massive lobbying efforts.

The world's top influenza researchers agreed to a voluntary moratorium on working with contagious, lab-altered forms of a particularly worrisome form of bird flu back in January. The hold was supposed to last just 60 days. It's now been more than six months, and scientists don't agree on what should happen next.

The Gaza Health Ministry says at least 42 people died Sunday and more than 50 people were wounded. Israeli Prime Minister Benjamin Netanyahu said the attacks were continuing at "full force."

A short-lived program in the early 2000s allowed married couples to consolidate their student loans for a lower interest rate. Now, with no legal way to separate the loans, some want changes.

NPR's A Martinez speaks to political strategist Matt Bennett on President Biden's messaging challenges, and what's needed to advance the White House agenda.

Staffers at Bloomberg News accused editors of spiking an investigative story to avoid the wrath of the Communist Party. But analysts say accusations of self-censorship go far beyond this one case. One American academic compares China's censorial authority to a "giant anaconda" — its mere presence enough to make people limit their behavior.

Lawmakers in both parties are trying to balance the competing needs of powerful stakeholders and consumers stuck with high bills. Despite progress, many insiders expect work to continue into 2020.

Congress has announced agreement on a $2 trillion economic relief package for the effects of COVID-19. Most households will get a relief check, and unemployment insurance has been greatly expanded.

President Trump said Wednesday that he would accept a foreign government's dirt on a 2020 rival. A look at foreign election interference — the focus of the Mueller report — and opposition research.

The House approved the final version of the annual defense with overwhelming bipartisan vote. The legislation is facing several veto threats from the president, which Congress may override.